ALLIANCEBERNSTEIN L.P. - SYNDAX PHARMACEUTICALS INC ownership

SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 75 filers reported holding SYNDAX PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of SYNDAX PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$1,750,183
-5.1%
85,250
+10.1%
0.00%0.0%
Q1 2024$1,843,548
+10.1%
77,4600.0%0.00%0.0%
Q4 2023$1,673,911
+48.8%
77,4600.0%0.00%
Q3 2023$1,124,719
-59.1%
77,460
-41.0%
0.00%
-100.0%
Q2 2023$2,748,737
+19.6%
131,330
+20.7%
0.00%0.0%
Q1 2023$2,298,278
-17.0%
108,8200.0%0.00%0.0%
Q4 2022$2,769,469
+5.9%
108,8200.0%0.00%0.0%
Q3 2022$2,615,000
+220.5%
108,820
+156.7%
0.00%
Q2 2022$816,000
+45.5%
42,400
+31.3%
0.00%
Q1 2022$561,000
-20.4%
32,300
+0.3%
0.00%
Q4 2021$705,000
+14.6%
32,2000.0%0.00%
Q3 2021$615,000
+11.2%
32,2000.0%0.00%
Q2 2021$553,000
-10.1%
32,200
+17.1%
0.00%
Q1 2021$615,000
+0.5%
27,5000.0%0.00%
Q4 2020$612,000
+23.1%
27,500
-18.4%
0.00%
Q3 2020$497,000
-0.4%
33,7000.0%0.00%
Q2 2020$499,000
+61.0%
33,700
+19.1%
0.00%
Q1 2020$310,000
+108.1%
28,300
+66.5%
0.00%
Q4 2019$149,000
+17.3%
17,0000.0%0.00%
Q3 2019$127,000
-7.3%
17,000
+15.6%
0.00%
Q2 2019$137,000
+90.3%
14,700
+7.3%
0.00%
Q1 2019$72,000
+18.0%
13,7000.0%0.00%
Q4 2018$61,000
-45.0%
13,7000.0%0.00%
Q3 2018$111,000
+15.6%
13,7000.0%0.00%
Q2 2018$96,000
-33.8%
13,700
+34.3%
0.00%
Q1 2018$145,000
+62.9%
10,2000.0%0.00%
Q4 2017$89,00010,2000.00%
Other shareholders
SYNDAX PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,168,691$15,224,0005.90%
Stonepine Capital Management, LLC 198,373$1,393,0000.85%
BVF INC/IL 1,233,618$8,660,0000.84%
683 Capital Management, LLC 375,000$2,633,0000.18%
Telemetry Investments, L.L.C. 49,000$344,0000.13%
ALGERT GLOBAL LLC 73,499$516,0000.11%
Boxer Capital, LLC 100,000$702,0000.08%
Tekla Capital Management LLC 200,000$1,404,0000.05%
Sofinnova Investments, Inc. 110,967$780,0000.05%
TIVERTON ASSET MANAGEMENT LLC 132,318$929,0000.05%
View complete list of SYNDAX PHARMACEUTICALS INC shareholders